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Central venous access device (CVAD) is defined as an intravascular catheter that terminates at or close to the heart or in one of the great vessels which is used for 
infusion, withdrawal of blood or hemodynamic monitoring [1]. 
The options of IV access in neonates available to clinicians have 
increased over the years. CVADs include peripherally inserted 
central catheters (PICCs), central venous catheters (CVCs), and 
umbilical venous catheters (UVCs).
Strict asepsis has to be maintained during insertion as well as 
maintenance of the catheter. Complications of inserting a CVAD 
including pneumothorax, hemothorax, hematoma, infections, and 
thrombosis are frequently reported in literature [2]. This study 
looks at the use of CVADs in neonates to determine their efficacy 
and complications in this population. The aim was to study the 
use of CVADs and their complications in neonates.
METHODOLOGY
This was a prospective observational study conducted in a tertiary 
care institution. The study group comprised 40 newborns over a 
period of 2 years. Prior approval from the Institutional Ethical 
Committee was obtained, and consent was taken from the parents 
or legal guardians before recruitment. All the newborn assessed 
to be requiring intravenous access for >7 days were eligible for 
inclusion in the study. This included neonates with prematurity, 
low birth weight, respiratory distress, congenital malformations, 
surgical conditions, etc. as shown in Fig. 1. Neonates with a 
central venous catheter placed at an outside facility and then 
referred to this hospital were excluded from the study.
Data collection included demographic profile of the patient 
(gestational age, sex, birth weight, and diagnosis of neonates); 
type of catheter (CVAD) used, size of lumen, site of insertion, 
number of attempts, type of fluids and medications administered 
(IV fluids, antibiotics, total parenteral nutrition [TPN], and blood 
and blood products), duration while the catheter was in situ, 
reason for removal, and details of events taking place while the 
catheter was in situ and complications of the catheters. Insertion 
of each CVAD even in the same patient was counted as a separate 
event. CVADs used in the study included PICCs and UVCs. 
The common types of catheters which were used included 1 Fr 
catheter with splitting needle (28G) with flow rate 0.7–1.6 ml/min 
for preterm neonates, 2 Fr catheters with splitting needle (24G) 
with flow rates 4–9 ml/min for term neonates, and Umbilical 
catheters (5Fr and 3.5 Fr).
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CVADs were inserted by resident with the guidance of a 
consultant under strict aseptic precautions as per Centre for Disease 
Control and Prevention (CDC) guidelines [3]. An appropriate 
catheter was chosen on the basis of gestational age of the patient. 
Only single lumen catheters were used. Catheter placement 
within a vein was confirmed by aspirating blood and irrigating 
with normal saline. No heparin was used during the procedure. 
Check X-ray was taken for catheter tip site confirmation in all 
the cases before using it. Monitoring for complications was done 
daily by inspection and/or by palpation. Catheter insertion site 
and dressing were not touched unless it was displaced. However, 
cleaning of part outside dressing was done with alcohol-based 
antiseptic twice daily. Care and maintenance of all catheters were 
done uniformly. Cultures were sent under aseptic conditions as 
per protocol at the time of suspicion of infection and at the time 
of removal of the catheter.
Central line-associated bloodstream infection (CLABSI) was 
established as per CDC definition which is a laboratory-confirmed 
bloodstream infection in a patient where the central line was 
in place for >2 calendar days (48 h) on the date of the event, 
with a day of device placement being day 1. The diagnosis of 
CLABSI was made when they meet one of the following criteria: 
(a) Criterion 1: Patient has a recognized pathogen cultured from 
one or more blood cultures and organism cultured from blood 
is not related to an infection at another site. (b) Criterion 2: 
Patient <1 year of age has at least one of the following signs or 
symptoms: Fever (>38°C core), hypothermia (<36°C core), and 
apnea or bradycardia and organism cultured from blood is not 
related to an infection at another site, and the same (matching) 
potential contaminant organism is cultured from two or more 
blood cultures drawn on separate occasions [1].
Colonization was considered when CVAD tip culture was 
positive, and criteria for CLABSI were not fulfilled. In cases 
of proven CLABSI, catheter was removed, and appropriate 
antibiotics were initiated. In cases of occlusion of the catheter, 
heparin flush was given, and an attempt was made to salvage the 
catheter, but in cases of failed attempt to salvage the catheter, 
it was removed. Catheter fracture was defined as a separation 
or cracking of catheter line components during use [4]. If the 
catheter was found to be fractured, it was removed. Accidental 
displacement of the catheter was also an indication for catheter 
removal. Catheter tip was sent for culture and sensitivity in all 
cases on removal. Results obtained were analyzed statistically.
RESULTS
A total of 40 CVADs were inserted in 32 neonates. This was due 
to more than one CVAD being used in a few patients. Patient 
characteristics are shown in Table 1. Mean birth weight of 
neonates was 1.63±0.92 kg, and the weight of the smallest baby 
was 570 g. PICCs insertions formed the bulk (85%) of devices 
used. UVCs were used in rest of the 6 (15%) cases, where, 
emergency intravenous access was required during resuscitation 
in 4 cases and for exchange transfusion in 2 cases. Most of the 
preterm neonates required 1 Fr PICC, and term neonates required 
2 Fr. UVCs 3.5 Fr was used for preterm and 5 Fr for term babies. 
Characteristics of the catheter used are shown in Table 2.
Basilic vein was the preferred site of insertion in almost half of 
the patients as majority of the cases had PICC in the upper limb. 
Other sites of insertion were saphenous vein, cephalic vein, and 
Table 1: Demographic profile of patients
Parameters n (%)
Sex
Male 30 (75)
Female 10 (25)
Weight (kg)
<1 16 (40)
1–<1.5 6 (15)
1.5–<2.0 6 (15)
2.0–<2.5 3 (7.5)
2.5 or more 9 (22.5)
Gestational age
Preterm 30 (75)
Term 10 (25)
Table 2: Characteristics of catheter and duration of insertion
Characteristics n (%)
Type of catheters
PICC 34 (85)
UVC 6 (15)
Number of attempts
One 27 (67.5)
Two 10 (25)
Three 3 (7.5)
Duration (weeks)
<1 15 (37.5)
<2 12 (30)
<3 12 (30)
<4 0
<5 1 (2.5)
PICC: Peripherally Inserted Central Catheters, UVC: Umbilical venous catheter
Figure 1: Indications of Central Venous Access Devices in neonates. 
ELBW: Extremely low birth weight, IEM: Inborn Error of 
metabolism, ICH: Intracranial hemorrhage, and PPHN: Persistent 
pulmonary hypertension of newborn
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umbilical vein. All the CVADs used were single lumen catheters. 
Regarding the number of attempts, single attempt at catheterization 
was successful in 67.5% of the neonates. All the CVADs (PICCs 
and UVCs) were used for giving IV fluids. 80% of the PICCs were 
used to administer TPN. In neonates, duration of the catheter was 
in the range of 2–32 days with a total period on the catheter of 
395 days with a mean duration of 9.9 days per patient.
CLABSI was the most common complication occurring 
in 7.5% of the total CVADs. Other complications are shown 
in Table 3 which conclude that two-third of the complications 
occurred in preterm and CLABSI rate was 7.5/1000 catheter 
days. Blood culture showed growth in 3 cases and the organisms 
grown were coagulase-negative Staphylococcus, E. coli, and 
Acinetobacter.
DISCUSSION
Placement of a CVAD is a potentially life-saving measure for 
neonates with poor peripheral venous access and gastrointestinal 
tract intolerance of adequate nutrition. In our study, we have 
inserted CVADs for prolonged administration of intravenous 
fluids, antibiotics, and TPN, and blood products. Overall, 
complication rates were low, occurring in only 22.5% of patients. 
Of these, infections were the most common comprising 34% 
of all complications, the majority of which occurred in preterm 
patients. Other complications included occlusion, fracture, and 
accidental displacement of the catheter.
In a study by Dheer et al., the most common indication of 
CVADs was failure of peripheral venous access in neonates 
(63.1%) [5]. In our study, however, neonates assessed to require 
a prolonged duration of intravenous access were subjected to 
CVADs. A single attempt at catheterization was successful in 
67.5% of neonates in our study. Almost identical results were 
seen in a study by Dheer et al., in which a single attempt was 
successful in 70.7% of the neonates.
CLABSI occurred in 7.5% of our patients, and the 
isolates were coagulase-negative staphylococcus, E.coli, and 
Acinetobacter. This is in accordance with published literature 
showing a similar organism. In 2010, a study by Sengupta et al. 
had shown coagulase-negative staphylococcus (n=7, 32%) 
in majority of the cases [6]. It was found that the duration of 
catheter use was critical for the occurrence of infections. One of 
the largest studies by Sengupta et al. had median time from line 
insertion to CLABSI in neonates of 18 days (9–22 days); while 
in our study, it was 11 days (4–18 days). This may be explained 
by the post-operative neonates in our study which forms a known 
high-risk group for complications. When catheters are in place 
for extended periods, the catheter hub probably plays a major role 
in providing access for the microorganism to the bloodstream 
by migrating endoluminally [7]. Therefore, the catheter should 
always be removed as soon as possible when not required.
CLABSI rate in our study was 7.5/1000 catheter days for 
neonates. These results reinforce the results of published data on 
the CLABSI. In a prospective study of 111 PICCs used for TPN 
in hospitalized children, Yeung et al. reported a rate of 6.4/1,000 
catheter days [8]. The incidence of PICC associated CLABSI over 
the 3-year period was 2.01/1000 catheter-days (95% confidence 
interval: 1.24-3.06) in a study by Sengupta et al. [6]. CVADs 
occlusion was a common problem, especially with the smaller 
gauge catheters. CVADs that did not flush or allowed flow were 
considered to be occluded. Whenever it did not resolve, CVAD 
was considered occluded (n=2, 5.0%), and it was removed. 
Occlusion was the second most common complication after 
the infections. In a large study by Thiagarajan et al., occlusion 
occurred in 7% of cases [9].
CVADs increase the risk of central venous thrombosis, with 
the concomitant potential risk of venous thromboembolism. 
Thrombotic clots can form if the venous wall is damaged during 
catheter insertion. Cochrane Database Systematic Review (2005) 
concluded that thrombosis occurs in 2–67% of CVADs [10]. Most 
of the thrombosis due to CVADs is asymptomatic [11]. Therefore, 
ultrasound follow-up that would reveal asymptomatic thrombosis 
should be performed regularly [12]. In our study, there was only 
one case of thromboembolism. Ultrasound was not routinely 
performed to look for thrombosis. However, in suspected cases 
where the ultrasound was performed, only one case of thrombosis 
was seen.
Sengupta et al. suggested that catheter duration was an 
important risk factor for PICC associated CLABSI in the 
neonatal intensive care unit (NICU). A significant daily increase 
in the risk of CLABSI may warrant replacement of a PICC if 
intravascular access is necessary beyond 35 days [6]. This study 
showed that the maximum number of the days PICC remain 
inserted in neonates in our NICU was 32 days. Either it was 
not required beyond this time or removed due to complication. 
Serious complications reported in the literature by Darling 
et al. include cardiac perforation, arteriovenous fistulas, nerve 
injuries (mostly brachial plexus injuries), cardiac tamponade, 
tension pneumothoraces, significant hemothoraces, delayed 
pneumothoraces, life-threatening arrhythmias, and thoracic duct 
Table 3: Distribution of complications in neonates
Complications Preterm neonates Term neonates Total neonates (%)
CLABSI 2 1 3 (7.5)
Occlusion 2 - 2 (5.0)
Suspected infection 1 1 2 (5.0)
Accidental displacement - 1 1 (2.5)
Thromboembolism 1 - 1 (2.5)
Total 6 3 9 (22.5)
CLABSI: Central Line‑Associated Bloodstream Infection
Gupta et al. Central venous access devices: uses and complications
Vol 5 | Issue 7 | July 2018 Indian J Child Health 472
injuries and death [13]. None of our patients had any of these 
serious complications which denote proper insertion and care as 
per protocol. Limitations of the study were small sample size; 
study considered for neonates only can be extended to uses and 
complications of CVADs in pediatric age group.
CONCLUSION
We conclude that central venous catheterization is a safe and 
efficient procedure with minimal complication in neonates. It is 
recommended to use CVADs whenever prolonged intravenous 
access requirement is expected. This study is extremely important 
to emphasize the uses and complications of CVADs in neonates in 
Indian practice and to encourage its use even in smaller neonatal 
centers also.
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